에이비온(주)

{
  "address": "서울특별시 구로구 디지털로",
  "brno": "214880****",
  "cappedWarning": false,
  "companyName": "에이비온주식회사",
  "estimatedAvgAnnualSalary": 56304768,
  "estimatedAvgMonthlySalary": 4692064,
  "fetchedAt": "2026-03-05T11:49:41.174Z",
  "industryCode": "730000",
  "industryName": "기타 인문 및 사회과학 연구개발업",
  "joinDate": "20070501",
  "last12MonthsHired": 2,
  "last12MonthsLeft": 2,
  "last12MonthsNetChange": 0,
  "leaveDate": null,
  "monthlyPensionAmount": 14709620,
  "monthlyTrend": [
    {
      "lostSubscribers": 2,
      "newSubscribers": 2,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6371589",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 33,
  "turnoverMonths": 1
}

{
  "address": "서울특별시 구로구",
  "ceo_name": "신영기",
  "certificate": [
    {
      "cert_number": "20090110995",
      "changes": "",
      "disclosure_date": "2009-12-10",
      "first_cert_date": "2009-12-10",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2009-12-10 ~ 2011-12-09"
    },
    {
      "cert_number": "20110109347",
      "changes": "",
      "disclosure_date": "2011-12-30",
      "first_cert_date": "2009-12-10",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2011-12-10 ~ 2013-12-09"
    },
    {
      "cert_number": "20130113240",
      "changes": "",
      "disclosure_date": "2013-12-17",
      "first_cert_date": "2009-12-10",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2013-12-10 ~ 2015-12-09"
    },
    {
      "cert_number": "20150114170",
      "changes": "",
      "disclosure_date": "2015-12-21",
      "first_cert_date": "2009-12-10",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2015-12-10 ~ 2017-12-09"
    },
    {
      "cert_number": "20170114964",
      "changes": "",
      "disclosure_date": "2017-12-21",
      "first_cert_date": "2009-12-10",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2017-12-10 ~ 2019-12-09"
    },
    {
      "cert_number": "20190114382",
      "changes": "",
      "disclosure_date": "2019-12-06",
      "first_cert_date": "2009-12-10",
      "no": "6",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-12-10 ~ 2021-12-09"
    },
    {
      "cert_number": "20211208020057",
      "changes": "",
      "disclosure_date": "2021-12-08",
      "first_cert_date": "2009-12-10",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2021-12-10 ~ 2024-12-09"
    },
    {
      "cert_number": "20250114020012",
      "changes": "",
      "disclosure_date": "2025-01-14",
      "first_cert_date": "2009-12-10",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2024-12-10 ~ 2027-12-09"
    }
  ],
  "company_name": "에이비온 주식회사",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 9422618000,
      "cost_of_sales": 1786558000,
      "current_assets": 16826504000,
      "current_liabilities": 7551925000,
      "gross_profit": 719961000,
      "net_income": -19925391000,
      "net_income_bs": -19925391000,
      "non_current_assets": 7177671000,
      "non_current_liabilities": 1351979000,
      "non_operating_expenses": 1864812000,
      "non_operating_income": 6539507000,
      "operating_profit": -24600086000,
      "revenue": 2506519000,
      "sga_expenses": 25320047000,
      "total_assets": 24004175000,
      "total_equity": 15100271000,
      "total_liabilities": 8903904000
    },
    "2023": {
      "capital_stock": 11012996000,
      "cost_of_sales": 1258465000,
      "current_assets": 11985718000,
      "current_liabilities": 28049114000,
      "gross_profit": 15842000,
      "net_income": -29210914000,
      "net_income_bs": -29210914000,
      "non_current_assets": 32611195000,
      "non_current_liabilities": 6568376000,
      "non_operating_expenses": 5603519000,
      "non_operating_income": 7089629000,
      "operating_profit": -30697024000,
      "revenue": 1274307000,
      "sga_expenses": 30712866000,
      "total_assets": 44596913000,
      "total_equity": 9979423000,
      "total_liabilities": 34617490000
    },
    "2024": {
      "capital_stock": 14318708000,
      "cost_of_sales": 537179000,
      "current_assets": 3499157000,
      "current_liabilities": 32071995000,
      "gross_profit": 222505000,
      "net_income": -43187725000,
      "net_income_bs": -43187725000,
      "non_current_assets": 59454526000,
      "non_current_liabilities": 2557676000,
      "non_operating_expenses": 18298054000,
      "non_operating_income": 8422558000,
      "operating_profit": -33312229000,
      "revenue": 759684000,
      "sga_expenses": 33534734000,
      "total_assets": 62953683000,
      "total_equity": 28324012000,
      "total_liabilities": 34629671000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "신약개발",
  "phone": "010-6813-****",
  "years": [
    2024,
    2023,
    2022
  ]
}